Wang, S., Sun, L., Shih, Y., Lu, T., Chen, Y., Hsu, S., . . . Lu, C. Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer. BMC.
Chicago Style (17th ed.) CitationWang, Shao-Jing, et al. Lenvatinib Plus Pembrolizumab Compared to Carboplatin Plus Paclitaxel for Carboplatin and Paclitaxel Pretreated, Recurrent, or Advanced Endometrial Cancer. BMC.
MLA (9th ed.) CitationWang, Shao-Jing, et al. Lenvatinib Plus Pembrolizumab Compared to Carboplatin Plus Paclitaxel for Carboplatin and Paclitaxel Pretreated, Recurrent, or Advanced Endometrial Cancer. BMC.
Warning: These citations may not always be 100% accurate.